Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Neoplasms × Irinotecan × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 33 Pancreatic Neoplasms 16 Colonic Neoplasms 11 Rectal Neoplasms 10 Stomach Neoplasms 9 Neoplasms 9 Small Cell Lung Carcinoma 7 Rhabdomyosarcoma 7 Neuroblastoma 7 Glioblastoma 7 Sarcoma, Ewing 6 Neoplasm Metastasis 6 Central Nervous System Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Glioma 4 Gastrointestinal Neoplasms 4 Brain Neoplasms 4 Advanced Solid Tumors 4 Sarcoma 3 Medulloblastoma 3 Gliosarcoma 3 Digestive System Neoplasms 3 Digestive System Diseases 3 Astrocytoma 3 Recurrence 2 Rectal Diseases 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasms by Site 2 Metastatic Pancreatic Adenocarcinoma 2

Interventions

pembrolizumab 6 aldesleukin 6 Cyclophosphamide 6 fludarabine phosphate 5 fludarabine 4 Nivolumab 4 durvalumab 3 Sorafenib 3 Radiotherapy 3 Filgrastim 3 Everolimus 3 Temozolomide 2 Peripheral Blood Stem Cell Transplantation 2 Isotretinoin 2 Interleukin-2 2 Interferon-alpha 2 Fluorouracil 2 Dexamethasone 2 Cyclosporine 2 Bevacizumab 2 vorolanib 1 tremelimumab 1 tocilizumab 1 talazoparib 1 sargramostim 1 poly ICLC 1 palbociclib 1 oblimersen 1 isoquercitrin 1 guadecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡